The Dixie Group, Inc.
The Dixie Group, Inc. (DXYN) Stock Competitors & Peer Comparison
See (DXYN) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DXYN | $0.48 | -1.88% | 6.7M | -0.62 | -$0.78 | N/A |
| RL | $298.23 | +0.98% | 18.1B | 25.72 | $11.60 | +1.14% |
| LEVI | $20.45 | -0.54% | 8.1B | 19.47 | $1.05 | +2.59% |
| GIL | $52.25 | +0.19% | 7.9B | 20.49 | $2.55 | +1.65% |
| VFC | $12.67 | -0.08% | 4.9B | 70.36 | $0.18 | +2.84% |
| PVH | $76.85 | +0.85% | 3.7B | 10.84 | $7.09 | +0.20% |
| KTB | $62.41 | -1.08% | 3.5B | 15.33 | $4.07 | +3.33% |
| COLM | $60.63 | +0.31% | 3.3B | 15.71 | $3.86 | +1.98% |
| UAA | $7.36 | +2.65% | 3B | -15.65 | -$0.47 | N/A |
| UA | $6.92 | +2.06% | 3B | -14.70 | -$0.47 | N/A |
Stock Comparison
DXYN vs RL Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, RL has a market cap of 18.1B. Regarding current trading prices, DXYN is priced at $0.48, while RL trades at $298.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas RL's P/E ratio is 25.72. In terms of profitability, DXYN's ROE is -0.60%, compared to RL's ROE of +0.30%. Regarding short-term risk, DXYN is less volatile compared to RL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check RL's competition here
DXYN vs LEVI Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, LEVI has a market cap of 8.1B. Regarding current trading prices, DXYN is priced at $0.48, while LEVI trades at $20.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas LEVI's P/E ratio is 19.47. In terms of profitability, DXYN's ROE is -0.60%, compared to LEVI's ROE of +0.20%. Regarding short-term risk, DXYN is less volatile compared to LEVI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LEVI's competition here
DXYN vs GIL Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, GIL has a market cap of 7.9B. Regarding current trading prices, DXYN is priced at $0.48, while GIL trades at $52.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas GIL's P/E ratio is 20.49. In terms of profitability, DXYN's ROE is -0.60%, compared to GIL's ROE of +0.26%. Regarding short-term risk, DXYN is less volatile compared to GIL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GIL's competition here
DXYN vs VFC Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, VFC has a market cap of 4.9B. Regarding current trading prices, DXYN is priced at $0.48, while VFC trades at $12.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas VFC's P/E ratio is 70.36. In terms of profitability, DXYN's ROE is -0.60%, compared to VFC's ROE of -0.13%. Regarding short-term risk, DXYN is less volatile compared to VFC. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check VFC's competition here
DXYN vs PVH Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, PVH has a market cap of 3.7B. Regarding current trading prices, DXYN is priced at $0.48, while PVH trades at $76.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas PVH's P/E ratio is 10.84. In terms of profitability, DXYN's ROE is -0.60%, compared to PVH's ROE of +0.08%. Regarding short-term risk, DXYN is less volatile compared to PVH. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check PVH's competition here
DXYN vs KTB Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, KTB has a market cap of 3.5B. Regarding current trading prices, DXYN is priced at $0.48, while KTB trades at $62.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas KTB's P/E ratio is 15.33. In terms of profitability, DXYN's ROE is -0.60%, compared to KTB's ROE of +0.59%. Regarding short-term risk, DXYN is less volatile compared to KTB. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check KTB's competition here
DXYN vs COLM Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, COLM has a market cap of 3.3B. Regarding current trading prices, DXYN is priced at $0.48, while COLM trades at $60.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas COLM's P/E ratio is 15.71. In terms of profitability, DXYN's ROE is -0.60%, compared to COLM's ROE of +0.13%. Regarding short-term risk, DXYN is less volatile compared to COLM. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check COLM's competition here
DXYN vs UAA Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, UAA has a market cap of 3B. Regarding current trading prices, DXYN is priced at $0.48, while UAA trades at $7.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas UAA's P/E ratio is -15.65. In terms of profitability, DXYN's ROE is -0.60%, compared to UAA's ROE of -0.07%. Regarding short-term risk, DXYN is less volatile compared to UAA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UAA's competition here
DXYN vs UA Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, UA has a market cap of 3B. Regarding current trading prices, DXYN is priced at $0.48, while UA trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas UA's P/E ratio is -14.70. In terms of profitability, DXYN's ROE is -0.60%, compared to UA's ROE of -0.07%. Regarding short-term risk, DXYN is less volatile compared to UA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UA's competition here
DXYN vs ZGN Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, ZGN has a market cap of 2.3B. Regarding current trading prices, DXYN is priced at $0.48, while ZGN trades at $9.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas ZGN's P/E ratio is 26.19. In terms of profitability, DXYN's ROE is -0.60%, compared to ZGN's ROE of +0.09%. Regarding short-term risk, DXYN is less volatile compared to ZGN. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check ZGN's competition here
DXYN vs AIN Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, AIN has a market cap of 2.2B. Regarding current trading prices, DXYN is priced at $0.48, while AIN trades at $72.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas AIN's P/E ratio is 29.00. In terms of profitability, DXYN's ROE is -0.60%, compared to AIN's ROE of +0.08%. Regarding short-term risk, DXYN is less volatile compared to AIN. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check AIN's competition here
DXYN vs HBI Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, HBI has a market cap of 1.6B. Regarding current trading prices, DXYN is priced at $0.48, while HBI trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas HBI's P/E ratio is -30.43. In terms of profitability, DXYN's ROE is -0.60%, compared to HBI's ROE of -3.99%. Regarding short-term risk, DXYN is less volatile compared to HBI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check HBI's competition here
DXYN vs GOOS Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, GOOS has a market cap of 1.4B. Regarding current trading prices, DXYN is priced at $0.48, while GOOS trades at $14.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas GOOS's P/E ratio is 20.19. In terms of profitability, DXYN's ROE is -0.60%, compared to GOOS's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to GOOS. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GOOS's competition here
DXYN vs FIGS Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, FIGS has a market cap of 1.1B. Regarding current trading prices, DXYN is priced at $0.48, while FIGS trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas FIGS's P/E ratio is 653.50. In terms of profitability, DXYN's ROE is -0.60%, compared to FIGS's ROE of +0.00%. Regarding short-term risk, DXYN is less volatile compared to FIGS. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check FIGS's competition here
DXYN vs GIII Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, GIII has a market cap of 1B. Regarding current trading prices, DXYN is priced at $0.48, while GIII trades at $24.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas GIII's P/E ratio is 5.67. In terms of profitability, DXYN's ROE is -0.60%, compared to GIII's ROE of +0.12%. Regarding short-term risk, DXYN is less volatile compared to GIII. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GIII's competition here
DXYN vs OXM Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, OXM has a market cap of 637.7M. Regarding current trading prices, DXYN is priced at $0.48, while OXM trades at $42.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas OXM's P/E ratio is 8.29. In terms of profitability, DXYN's ROE is -0.60%, compared to OXM's ROE of +0.13%. Regarding short-term risk, DXYN is less volatile compared to OXM. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check OXM's competition here
DXYN vs SGC Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, SGC has a market cap of 175.5M. Regarding current trading prices, DXYN is priced at $0.48, while SGC trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas SGC's P/E ratio is 24.95. In terms of profitability, DXYN's ROE is -0.60%, compared to SGC's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to SGC. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check SGC's competition here
DXYN vs LAKE Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, LAKE has a market cap of 142.3M. Regarding current trading prices, DXYN is priced at $0.48, while LAKE trades at $14.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas LAKE's P/E ratio is -4.89. In terms of profitability, DXYN's ROE is -0.60%, compared to LAKE's ROE of -0.00%. Regarding short-term risk, DXYN is less volatile compared to LAKE. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LAKE's competition here
DXYN vs UFI Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, UFI has a market cap of 86.5M. Regarding current trading prices, DXYN is priced at $0.48, while UFI trades at $4.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas UFI's P/E ratio is -2.17. In terms of profitability, DXYN's ROE is -0.60%, compared to UFI's ROE of -0.16%. Regarding short-term risk, DXYN is less volatile compared to UFI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UFI's competition here
DXYN vs CULP Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, CULP has a market cap of 57M. Regarding current trading prices, DXYN is priced at $0.48, while CULP trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas CULP's P/E ratio is -2.97. In terms of profitability, DXYN's ROE is -0.60%, compared to CULP's ROE of -0.20%. Regarding short-term risk, DXYN is less volatile compared to CULP. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check CULP's competition here
DXYN vs JRSH Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, JRSH has a market cap of 44.1M. Regarding current trading prices, DXYN is priced at $0.48, while JRSH trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas JRSH's P/E ratio is -49.57. In terms of profitability, DXYN's ROE is -0.60%, compared to JRSH's ROE of -0.01%. Regarding short-term risk, DXYN is less volatile compared to JRSH. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JRSH's competition here
DXYN vs JL Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, JL has a market cap of 20.3M. Regarding current trading prices, DXYN is priced at $0.48, while JL trades at $6.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas JL's P/E ratio is 0.89. In terms of profitability, DXYN's ROE is -0.60%, compared to JL's ROE of -0.06%. Regarding short-term risk, DXYN is less volatile compared to JL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JL's competition here
DXYN vs VNCE Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, VNCE has a market cap of 20M. Regarding current trading prices, DXYN is priced at $0.48, while VNCE trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas VNCE's P/E ratio is -0.70. In terms of profitability, DXYN's ROE is -0.60%, compared to VNCE's ROE of -0.60%. Regarding short-term risk, DXYN is less volatile compared to VNCE. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check VNCE's competition here
DXYN vs PMNT Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, PMNT has a market cap of 11.3M. Regarding current trading prices, DXYN is priced at $0.48, while PMNT trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas PMNT's P/E ratio is -0.37. In terms of profitability, DXYN's ROE is -0.60%, compared to PMNT's ROE of -6.27%. Regarding short-term risk, DXYN is less volatile compared to PMNT. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check PMNT's competition here
DXYN vs LLL Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, LLL has a market cap of 10.8M. Regarding current trading prices, DXYN is priced at $0.48, while LLL trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas LLL's P/E ratio is -0.10. In terms of profitability, DXYN's ROE is -0.60%, compared to LLL's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to LLL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LLL's competition here
DXYN vs NCI Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, NCI has a market cap of 8.5M. Regarding current trading prices, DXYN is priced at $0.48, while NCI trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas NCI's P/E ratio is 8.04. In terms of profitability, DXYN's ROE is -0.60%, compared to NCI's ROE of +0.02%. Regarding short-term risk, DXYN is less volatile compared to NCI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check NCI's competition here
DXYN vs JXJT Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, JXJT has a market cap of 4.9M. Regarding current trading prices, DXYN is priced at $0.48, while JXJT trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas JXJT's P/E ratio is 1.47. In terms of profitability, DXYN's ROE is -0.60%, compared to JXJT's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to JXJT. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JXJT's competition here
DXYN vs DLA Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, DLA has a market cap of 4.1M. Regarding current trading prices, DXYN is priced at $0.48, while DLA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas DLA's P/E ratio is -0.06. In terms of profitability, DXYN's ROE is -0.60%, compared to DLA's ROE of -0.36%. Regarding short-term risk, DXYN is less volatile compared to DLA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check DLA's competition here
DXYN vs XELB Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, XELB has a market cap of 3.7M. Regarding current trading prices, DXYN is priced at $0.48, while XELB trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas XELB's P/E ratio is -0.19. In terms of profitability, DXYN's ROE is -0.60%, compared to XELB's ROE of -0.54%. Regarding short-term risk, DXYN is less volatile compared to XELB. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check XELB's competition here
DXYN vs SQBG Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, SQBG has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.48, while SQBG trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas SQBG's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.60%, compared to SQBG's ROE of -1.42%. Regarding short-term risk, DXYN is less volatile compared to SQBG. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check SQBG's competition here
DXYN vs KBSF Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, KBSF has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.48, while KBSF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas KBSF's P/E ratio is -1.46. In terms of profitability, DXYN's ROE is -0.60%, compared to KBSF's ROE of -0.10%. Regarding short-term risk, DXYN is less volatile compared to KBSF. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check KBSF's competition here
DXYN vs EVK Comparison July 2025
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6.7M. In comparison, EVK has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.48, while EVK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.62, whereas EVK's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.60%, compared to EVK's ROE of -0.00%. Regarding short-term risk, DXYN is less volatile compared to EVK. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check EVK's competition here